Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Carbonxt Group - FY22 Results Announcement (ASX:CG1)

Highlights: Record annual revenues of $18.4 million, up 49% on FY21. Exchange rate fluctuations positively impacted comparative revenue accounting by $515k or 2.9%. Pellet sales acco...read more

Carbonxt Group - Appendix 4G and Corporate Governance Statement (ASX:CG1)

To view the appendix, download the attached PDF.

Carbonxt Group - Extension of Closing Date for Retail Entitlement Offer (ASX:CG1)

Carbonxt Group Limited (ASX:CG1) (Carbonxt or Company) wishes to advise that the closing date for the retail component of its partially underwritten 1-for-4 non-renounceable accelerated entitlement ...read more

Careteq - Full Year Results Presentation (ASX:CTQ)

To view the presentation, download the attached PDF.

Careteq - Appendix 4G (ASX:CTQ)

To view the appendix, download the attached PDF.

Careteq - Full Year Results (ASX:CTQ)

Highlights: -- Rapidly growing sales pipeline and strong balance sheet put Careteq at a potential growth inflection point in the current financial year -- Currently managing >60 active sales ...read more

Careteq 2022 Annual Report (ASX:CTQ)

CARETEQ is an ASX-listed, health-tech company delivering a portfolio of innovative solutions in the aged care and healthcare sectors. Founded in 2016 with the mission of improving wellbeing for all ...read more

Careteq - Appendix 4E (ASX:CTQ)

To view the appendix, download the attached PDF.

Chimeric Therapeutics - Patent received in Japan for CLTX CAR technology (ASX:CHM)

Chimeric Therapeutics (ASX:CHM, “Chimeric”), a clinical-stage cell therapy company and an Australian leader in cell therapy, is pleased to announce that the Japan Patent Office has issue...read more

Carbonxt Group - Successful completion of Institutional Entitlement Offer (ASX:CG1)

Highlights: -- Cabonxt completed the Institutional Entitlement Offer component of its 1-for-4 partially underwritten, non-renounceable accelerated entitlement offer to raise a maximum of $6.6 mil...read more

Carbonxt Group - Management Presentation (ASX:CG1)

To view the presentation, download the attached PDF.

Carbonxt Group - Cleansing Notice (ASX:CG1)

This notice is given by Carbonxt Group Limited CAN 097 247 464 (ASX: CG1) (Carbonxt or the Company) under section 708AA(2)(f) of the Corporations Act 2001 (Cth) (the Corporations Act) as notionally ...read more

Carbonxt Group - Proposed issue of securities - CG1 (ASX:CG1)

To view the proposed issue of securities, download the attached PDF.

Carbonxt Group - Capital raise to support Kentucky production facility and JV (ASX:CG1)

Highlights: -- Cabonxt has signed a term sheet for 50% ownership in a new state-of-the-art activated carbon plant located in eastern Kentucky, USA in joint venture with KCP, an established and le...read more

Carbonxt Group - June 2022 Quarterly Activities Report (ASX:CG1)

Highlights -- Quarterly customer receipts of A$4.1m -- an increase of 6% compared to prior quarter, and up 50% on the previous corresponding quarter. -- Accounts receivable have increased by A$0...read more

Viewing: 106 - 120 of 200 Previous | Next